Myelodysplastic/Myeloproliferative Neoplasms
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
52-65
Author(s):
Cherie H. Dunphy
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
14-29
Author(s):
Robert P. Hasserjian
Editorial [Hot Topic: The Current World Health Organization Classification of the Myeloproliferative and Myelodysplastic/myeloproliferative Neoplasms and Correlation with Pertinent Targeted Therapy (Guest Editor: Cherie H. Dunphy)]
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
2-2
Author(s):
Cherie H. Dunphy
Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
107-123
Author(s):
S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge
The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
85-96
Author(s):
L. A. Stivala, O. Cazzalini and E. Prosperi
Polysaccharide-K (PSK) in Cancer - Old Story, New Possibilities?
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
757-762
Author(s):
C. Sun, A.H. Rosendahl, X.D. Wang, D.Q. Wu and R. Andersson
Therapeutic Polycomb Targeting in Human Cancer
Journal:
Recent Patents on Regenerative Medicine
Volume:
2
Page:
22-29
Author(s):
Lorena Arranz, Antonio Herrera-Merchan and Susana Gonzalez
The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
51-63
Author(s):
H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda and P. Valent
Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Journal:
Current Drug Delivery
Volume:
9
Page:
30-40
Author(s):
Aisha Masood, Mohammad A. Shahshahan and Ali R. Jazirehi
Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease
Journal:
Current Drug Delivery
Volume:
9
Page:
41-51
Author(s):
Erin Reid, Ajay Nooka, Jawaunna Blackmon and Mary Jo Lechowicz